New research shows that prescription-strength ibuprofen, naproxen and other pain relievers could contribute to a higher risk for heart failure for some individuals, reports CBS News.

Xeltis, producers of clinical-stage medical devices, has successfully completed three implants of the first heart valve that supports cardiovascular restoration in three pediatric patients.

Doctors can lead from medical errors, but the lack of disclosure and a formal record keeps helpful information in the dark.  

The Department of Defense (DOD) awarded a $10 million grant to researchers at Cedars-Sinai Heart Institute for a cardiac cell therapy trial for patients with heart failure with preserved ejection fraction.

Affecting over 11 million people, non-valvular atrial fibrillation (AF) has become the more common form of cardiac arrhythmia. As a way to prevent and improve the care of this disease the World Heart Federation (WHF) has launched an international Roadmap to combat AF.

A systematic review and meta-analysis of six observational studies found that the use of implantable cardioverter-defibrillators (ICDs) was associated with a 39 percent relative reduction in mortality among advanced heart failure patients with left ventricular assist devices (LVADs).

The FDA classified two recalls of the HeartWare ventricular assist device (HVAD) system as class I recalls.

A single-arm study found that all of the patients with moderate or severely calcified peripheral lesions who received the lithoplasty system achieved the primary efficacy endpoint of procedural success.